Morgan Stanley’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
|
|||||
|
2025
Q1 | $5.41M | Buy |
|
|||||
|
2024
Q4 | $5.94M | Buy |
|
|||||
|
2024
Q3 | $7.17M | Sell |
|
|||||
|
2024
Q2 | $9.61M | Buy |
|
|||||
|
2024
Q1 | $1.94M | Buy |
|
|||||
|
2023
Q4 | $1.72K | Buy |
|
|||||
|
2023
Q3 | $564 | Sell |
|
|||||
|
2023
Q2 | $1.49K | Sell |
|
|||||
|
2023
Q1 | $3.96K | Sell |
|
|||||
|
2022
Q4 | $36.2K | Sell |
|
|||||
|
2022
Q3 | $88K | Sell |
|
|||||
|
2022
Q2 | $148K | Buy |
|
|||||
|
2022
Q1 | $418K | Sell |
|
|||||
|
2021
Q4 | $932K | Buy |
|
|||||
|
2021
Q3 | $1.54M | Sell |
|
|||||
|
2021
Q2 | $1.36M | Buy |
|
|||||
|
2021
Q1 | $880K | Sell |
|
|||||
|
2020
Q4 | $1.01M | Buy |
|
|||||
|
2020
Q3 | $249K | Buy |
|
|||||
|
2020
Q2 | $235K | Buy |
|
|||||
|
2020
Q1 | $16K | Sell |
|
|||||
|
2019
Q4 | $276K | Buy |
|
|||||
|
2019
Q3 | $63K | Sell |
|
|||||
|
2019
Q2 | $337K | Buy |
|
|||||
|
2019
Q1 | $71K | Sell |
|
|||||
|
2018
Q4 | $202K | Sell |
|
|||||
|
2018
Q3 | $285K | Sell |
|
|||||
|
2018
Q2 | $427K | Buy |
|
|||||
|
2018
Q1 | $73K | Buy |
|
|||||
|
2017
Q4 | $16K | Hold |
|
|||||
|
2017
Q3 | $15K | Buy |
|
|||||
|
2017
Q2 | $11K | Buy |
|
|||||
|
2017
Q1 | $20K | Hold |
|
|||||
|
2016
Q4 | $12K | Sell |
|
|||||
|
2016
Q3 | $25K | Buy |
|